Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.9166
-0.0634 (-6.47%)
At close: Jul 18, 2025, 4:00 PM
0.9298
+0.0132 (1.44%)
After-hours: Jul 18, 2025, 7:54 PM EDT
Iterum Therapeutics Employees
Iterum Therapeutics had 9 employees as of December 31, 2024. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
n/a
Profits / Employee
-$2,507,111
Market Cap
36.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ITRM News
- 16 days ago - Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 18 days ago - Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth - GlobeNewsWire
- 23 days ago - Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence - GlobeNewsWire
- 5 weeks ago - Iterum Therapeutics Announces Partnership for Commercialization Services - GlobeNewsWire
- 2 months ago - Iterum Therapeutics Announces Extension of Term of Promissory Note - GlobeNewsWire
- 2 months ago - Iterum Therapeutics plc (ITRM) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Iterum Therapeutics Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire